Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $268.60 | Total: $1,343.00 |
| 1 | 10 | $227.52 | Total: $2,275.20 |
| 1 | 25 | $192.76 | Total: $4,819.00 |
| 1 | 50 | $164.32 | Total: $8,216.00 |
| 1 | 100 | $142.20 | Total: $14,220.01 |
Overview
Sonrotoclax is a potent, orally active inhibitor of Bcl2, demonstrating effective cell-killing activity against a range of lymphoma and leukemia cell lines [1].
Chemical Properties
| Molecular Formula | C49H59N7O7S |
| Molecular Weight | 890.1 |
| CAS Numbers | 2383086-06-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC(C1=C(C=CC=C1)[C@H]2N(CCC2)C3CC4(CCN(C5=CC(OC6=CN=C(NC=C7)C7=C6)=C(C=C5)C(NS(=O)(C8=CC([N+]([O-])=O)=C(C=C8)NC[C@@H]9CC[C@@](O)(CC9)C)=O)=O)CC4)C3)C |
Storage and Handling
0C Short Term, -20C Long Term
References
Nan HU, et al. Methods of cancer treatment using bcl-2 inhibitor. WO2021110102A1.